Clinical Trials on Antivirals/HIV

Total 14424 results

University Hospital, Limoges

Recruiting

AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients (NAViRe)

Cytomegalovirus Infections | Hematopoietic Stem Cell Transplantation | Antivirals | Antiviral Drug Resistance

France
Bristol-Myers Squibb

Completed

Drug Interaction Study

Antivirals/HIV

United States
Castagna Antonella
ViiV Healthcare

Recruiting

Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease. (PRESTIGIO)

HIV-1-infection | Multi-Antiviral Resistance

Italy
Assiut University

Unknown

Effect of Direct AntiViral Drugs of Chronic HCV on eGFR in Assuit Universiry Hospital

Antiviral Drug
Assistance Publique - Hôpitaux de Paris
Gilead Sciences

Terminated

HCV, HBV, HIV Testing During Consultation With Anesthesiologist (SAHARA)

Hiv | HBV | HCV

France
ANRS, Emerging Infectious Diseases

Unknown

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection (ANRSCO23CUPILT)

Liver Transplantation | HCV Recurrence | Direct-acting Antiviral Agents

France
University of California, Los Angeles
Gilead Sciences

Completed

Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) (UCLACAREMITO)

HIV/AIDS | Mitochondrial Alteration | Antiviral Toxicity | Antiviral Drug Adverse Reaction

United States
Perouse Medical
Eclevar Medtech

Completed

A Retrospective, Observational, Monocenter, Study to Describe the Utilization and Overall Safety and Performance of POLYSITE®/SEESITE® Implantable Ports

Chemotherapy | Antibiotics | Parenteral Nutrition | Venous Access | Venous System | Antiviral | Transfusion Blood

France
Perouse Medical
Eclevar Medtech

Recruiting

A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports

Chemotherapy | Blood Transfusion | Antibiotics | Parenteral Nutrition | Antiviral Drugs | Veinous | Blood Derivatives Transfusion | PMCF Study

France
National Institute of Allergy and Infectious Diseases...

Recruiting

Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products

Physiological Effects of Drugs | Anti-Infective Agents | Vaccines | Immunologic Factors | Antiviral Agents

United States
Assiut University

Unknown

Quality of Life in Patients With HCV Related Liver Cirrhosis Before and After Direct Acting Antiviral Drugs

HCV Related Liver Cirrhosis Direct Acting Antiviral Drugs
Theratechnologies
ICON Clinical Research; Excelsus Statistics Inc.; Health Psychology Research...

Recruiting

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab (PROMISE-US)

HIV Infections | Multi-Antiviral Resistance

United States
CONRAD
United States Agency for International Development (USAID); Eastern Virginia...

Completed

Safety, PK, and PD Study of a Vaginal Insert Containing TAF and EVG

Hiv | HSV

United States
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb; National Institute of Allergy and Infectious Diseases...

Completed

Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV

HIV-HCV

United States
Dong-Gun Lee

Enrolling by invitation

Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation

HBV | Hematopoietic Stem Cell Transplantation | Hepatitis B Reactivation | Antiviral Drug

Korea, Republic of
Assistance Publique Hopitaux De Marseille

Unknown

Analysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents (DAA) on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV Patients (HCURE)

HIV Associated HCV

France
Dartmouth-Hitchcock Medical Center

Completed

HSV Oral Reactivation in Children

HIV | HSV-1

Tanzania
Fred Hutchinson Cancer Center
Institute for the Development of Africa

Completed

Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon

HIV Infections | HIV-1 and HSV-2 Coinfection

Cameroon
Assiut University

Unknown

Effect Of DAAs For Treatment Of HCV On Normal Kidney

Antiviral Drug Adverse Reaction
University of Milan

Unknown

Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults

HIV | HPV

Italy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Duke-NUS Medical School (Singapore)

Not yet recruiting

Rapid T-cell Analysis Test in Patients With Chronic HBV and HBV/HDV Disease (BDTc)

HBV | HBV/HDV

Italy
Universita di Verona

Not yet recruiting

Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome (LUNGVIR)

HIV | HBV | Long COVID | NSCLC Stage IV | HCV

Italy
Alexandria University

Unknown

Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse

Hepatitis C | Relapse | Antivirals

Egypt
Yunnan AIDS Care Center

Unknown

Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients

HIV Infections | HBV Coinfection

China
Yale University
National Institute on Drug Abuse (NIDA); NYU Langone Health; Kenya National AIDS...

Completed

Testing and Linkage to Care for Injecting Drug Users in Kenya

HIV Infection | HCV Coinfection

Kenya
Hospital de Clinicas de Porto Alegre
Universidade Federal de Santa Maria

Completed

Folinic Acid: Supplementation and Therapy (FAST)

HIV Infection | HCV Coinfection
National Institute of Allergy and Infectious Diseases...

Completed

A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults

Respiratory Syncytial Virus Infection | Antiviral Prophylaxis

United States
Institute of HIV Research and Innovation Foundation...
amfAR, The Foundation for AIDS Research

Recruiting

The South-East Asian Transgender Health Cohort (SEATrans)

HIV | HCV | STIs

Philippines, Thailand, Vietnam
Assistance Publique Hopitaux De Marseille

Completed

Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients

HIV-HCV Co-infected Patients

France
Institute of HIV Research and Innovation Foundation...

Recruiting

KP-Led Same Day HCV Test and Treat Study (479/65)

HCV, HIV

Thailand
Xiangya Hospital of Central South University

Completed

The Renal Safety of Tenofovir Alafenamide in HBV-related Acute-on-chronic Liver Failure: Real-World Study

Antiviral Drugs

China
Fundacion para la Investigacion Biomedica del Hospital...
Instituto de Salud Carlos III

Completed

Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) (DRIVE)

HIV Infection | HCV Coinfection

Spain
Hoffmann-La Roche

Terminated

Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)

HIV/HCV Coinfection

Belgium
Juan Macías
Spanish National Health System

Unknown

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

HIV Infection | HCV Coinfection

Spain
Bayside Health
Gilead Sciences; Centre for Clinical Research Excellence in Infectious Diseases...

Unknown

HIV-HBV Co-Infection and Liver Disease

HIV Infections | HIV-HBV Co-Infection

Australia
Columbia University
National Institute on Drug Abuse (NIDA); University of Miami; Weill Medical College... and other collaborators

Recruiting

Integrated HIV Prevention and HCV Care for PWID (M2HepPrEP)

HIV Prevention | Opioid Use | HCV | Intravenous Drug Usage

Canada, United States
University of Melbourne
Melbourne Health; National Health and Medical Research Council, Australia; University... and other collaborators

Active, not recruiting

Towards a Functional Cure for HBV - The COMMIT Cohort Study (COMMIT)

Hiv | HBV Coinfection

India, Malaysia, Thailand
Johns Hopkins University

Completed

deLIVER: Direct Acting Antiviral Effects on the Liver (deLIVER)

HIV | Liver Disease | HCV Coinfection

United States
University Hospital, Rouen
Hoffmann-La Roche

Terminated

Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules (AMPHORE)

HIV Infections | HIV1 Infection

France
ANRS, Emerging Infectious Diseases

Not yet recruiting

Study Evaluating the Safety, in Terms of HBV Virological Control at 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected With the HIV-1 and HBV Viruses (BI-LIGHT)

HIV Infections | HBV Coinfection
University of Washington
National Institute of Allergy and Infectious Diseases (NIAID); Kenya Medical...

Completed

Immunogenetic Modulators of Mucosal Protection From HIV-1 (Kinga)

HIV Infections | HSV-2 Infection

Kenya
Fundacion SEIMC-GESIDA
ViiV Healthcare

Completed

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir (FOSTER-C)

HCV Coinfection | Chronic HIV Infection

Spain
Postgraduate Institute of Medical Education and...

Unknown

HCV RAS Testing in Public Health Programs (RAS-HCV)

Hepatitis C | Public Health | Direct Acting Antiviral Agents | Resistance Associated Substitutions

India
ANRS, Emerging Infectious Diseases
Bristol-Myers Squibb

Completed

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders (QUADRIH)

HCV-HIV Co-Infection

France
Tufts Medical Center
Merck Sharp & Dohme LLC

Active, not recruiting

Letermovir Use in Heart Transplant Recipients

Neutropenia | Cytomegalovirus Infections | Cytomegalovirus Disease | Heart Transplant Infection | Antiviral Toxicity

United States
University of Texas Southwestern Medical Center

Completed

An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

COVID-19 | Respiratory Viral Infection | Antiviral Treatment

United States
Novartis

Completed

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations

Taiwan
Peking Union Medical College Hospital

Recruiting

Gut and Vaginal Microbiota Profile Study for HIV Women

HIV Infections | HPV | Vaginal Microbiota

China
Hospital Universitario de Valme
Instituto de Salud Carlos III

Unknown

Prediction of Liver-related Outcomes After HCV Cure

Hepatocellular Carcinoma | Hepatitis C, Chronic | Hepatic Decompensation | Sustained Virological Response | Direct-acting Antivirals

Spain
Kenya Medical Research Institute
Merck Sharp & Dohme LLC; University of Washington

Completed

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

HPV Infection | HPV Vaccine | HIV-1-infection

Kenya

Clinical Trials on Antivirals/HIV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations